I guess a lot of the reaction is due to previous failures (Spheramine, Ceregene), that members of the board enrolled onto. I share your excitement however I too am scared that something will come out of the woodwork and knock us back, (cost, results not good enough, there is a "y" in the day of the week, etc).

Reminds me if Howardh is watching this, I know he pinned a lot of faith in Kaplitt and During, (founders of Neurologix), it would be great to hear his reaction.

In the meantime you're right, this could potentially be the best news since DBS, (perhaps that came out wrong), and keep on posting Paula

Neil.